WILMINGTON, Del. Anglo-Swedish drug maker AstraZeneca has created a savings card for users of one of its breast cancer drugs, AstraZeneca said Thursday.
The program, for women Arimidex (anastrozole), is designed to save patients up to $300. The program is tied to copays, so if a patient pays a $75 copay, AstraZeneca will cover $25, or $50 if the patient pays a $100 copay.
Arimidex treats hormone receptor-positive early breast cancer in postmenopausal women.